Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2025-09-03 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instruments Co., Ltd. regarding the progress of cash management using idle raised funds. It details the board meeting approval, amounts involved, types of financial products purchased, risk controls, and compliance with stock exchange disclosure rules. The document is a disclosure of ongoing financing activities related to the use of idle raised funds for cash management, including structured deposits and bank products. It does not contain financial statements, audit opinions, or detailed financial results. It is not a full financial report, earnings release, or management discussion. The document is a regulatory announcement about capital/financing activities, specifically the use of idle raised funds for cash management, which fits the Capital/Financing Update (CAP) category. The document length is 3619 characters, which is relatively short but contains substantive disclosure about financing activities rather than just a notice or report publication announcement. Therefore, the best classification is CAP with high confidence.
2025-09-03 Chinese
募集资金存放、管理与实际使用情况的专项报告
Capital/Financing Update Classification · 100% confidence The document is a detailed report on the use, management, and status of funds raised through a public offering of shares by Shanghai Boxun Medical Biological Instruments Co., Ltd. It includes specifics on the amount raised, timing, usage, balances, and compliance with regulatory requirements. The document references approvals from the China Securities Regulatory Commission and the Beijing Stock Exchange, and includes audit verification reports from an accounting firm. The content focuses on the management and actual use of the raised capital, including cash management and investment of idle funds, and confirms no misuse or changes in the use of funds. This type of document is a specialized report on capital raising and fund usage, which fits the definition of a Capital/Financing Update (CAP) rather than a general financial report or announcement. The length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-08-26 Chinese
2025年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '半年度报告 2025' which translates to '2025 Half-Year Report'. It contains detailed financial data including income, profit, asset-liability structure, business overview, risk factors, and operational analysis for the period 2025.01.01 to 2025.06.30. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. It explicitly states it is a half-year report and includes comprehensive financial statements and management discussion. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
第四届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the ninth meeting of the fourth board of directors of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the meeting's attendance, the approval of the 2025 semi-annual report and its summary, and a special report on the management and use of raised funds. The document references that the actual reports are disclosed separately on the Beijing Stock Exchange information disclosure platform with specific announcement numbers. The document itself does not contain the financial data or the full reports but is an official announcement of board meeting decisions and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters. The document length is short (1513 characters), and it is not the report itself but an announcement of resolutions related to reports. Therefore, the correct classification is MANG with high confidence.
2025-08-26 Chinese
国金证券股份有限公司关于上海博迅医疗生物仪器股份有限公司2025年半年度持续督导跟踪报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025 Half-Year Continuous Supervision Tracking Report' issued by a sponsoring securities company regarding a listed company. It references regulatory frameworks related to securities issuance and listing, and details ongoing supervision activities, including review of disclosure documents, internal controls, use of raised funds, and governance. The document contains substantive content about the company's operations and compliance over a half-year period, including tables summarizing findings and measures taken. The length is under 5,000 characters but the content is a detailed half-year supervisory report, not merely an announcement or certification. This fits the definition of an Interim / Quarterly Report (IR), as it is a comprehensive report for a period shorter than a full fiscal year with substantive data and analysis, not just a notice or announcement. Therefore, the correct classification is IR with high confidence. H1 2025
2025-08-26 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "半年度报告摘要" which translates to "Half-Year Report Summary" or "Interim Report Summary" for the year 2025. It contains detailed financial data for the half-year period, including assets, liabilities, net profit, earnings per share, and other financial metrics. It also includes company business descriptions, shareholder information, and other operational details. The document explicitly states it is an unaudited half-year report summary and references the full half-year report for more details. This matches the characteristics of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. The document length (4707 characters) is sufficient to contain actual financial data, not just an announcement or certification. Therefore, the correct classification is IR with high confidence. H1 2025
2025-08-26 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.